Altaf A. Dar

3.4k total citations
51 papers, 2.5k citations indexed

About

Altaf A. Dar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Altaf A. Dar has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 30 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Altaf A. Dar's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Altaf A. Dar is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (16 papers) and Circular RNAs in diseases (13 papers). Altaf A. Dar collaborates with scholars based in United States, Germany and Australia. Altaf A. Dar's co-authors include Shahana Majid, Rajvir Dahiya, Sharanjot Saini, Wael El‐Rifai, Soichiro Yamamura, Yuichiro Tanaka, Guoren Deng, Mohammed Kashani–Sabet, Mehdi Nosrati and Varahram Shahryari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Altaf A. Dar

50 papers receiving 2.5k citations

Peers

Countries citing papers authored by Altaf A. Dar

Since Specialization

Citations

This map shows the geographic impact of Altaf A. Dar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Altaf A. Dar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Altaf A. Dar more than expected).

Fields of papers citing papers by Altaf A. Dar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Altaf A. Dar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Altaf A. Dar. The network helps show where Altaf A. Dar may publish in the future.

Co-authorship network of co-authors of Altaf A. Dar

This figure shows the co-authorship network connecting the top 25 collaborators of Altaf A. Dar. A scholar is included among the top collaborators of Altaf A. Dar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Altaf A. Dar. Altaf A. Dar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK 2024 ·Journal of Translational Medicine ·Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, (unknown), Robyn L. Jones, (unknown), Mehdi Nosrati, Pierre‐Yves Desprez, Nathan Salomonis, Yihui Shi, Altaf A. Dar, Mohammed Kashani–Sabet	1
2	Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility 2021 ·Cancer Research ·David de Semir, Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, James R. Miller, Stanley P. L. Leong, Kevin B. Kim, Wilson Liao, Liliana Soroceanu, Sean D. McAllister, Robert J. Debs, Dirk Schadendorf, Sancy A. Leachman, James E. Cleaver, Mohammed Kashani–Sabet	12
3	PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer 2018 ·Proceedings of the National Academy of Sciences ·David de Semir, Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, (unknown), (unknown), (unknown), Meenakshi Venkatasubramanian, James R. Miller, Pierre‐Yves Desprez, Sean D. McAllister, Liliana Soroceanu, Robert J. Debs, Nathan Salomonis, Dirk Schadendorf, James E. Cleaver, Mohammed Kashani–Sabet	16
4	Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma 2018 ·Clinical Cancer Research ·Vladimir Bezrookove, Mehdi Nosrati, James R. Miller, David de Semir, Altaf A. Dar, (unknown), (unknown), Antje Sucker, Alexander J. Lazar, Jeffrey E. Gershenwald, Michael A. Davies, Dirk Schadendorf, Mohammed Kashani–Sabet	10
5	MicroRNA-720 Regulates E-cadherin–αE-catenin Complex and Promotes Renal Cell Carcinoma 2017 ·Molecular Cancer Therapeutics ·Nadeem S. Bhat, (unknown), Altaf A. Dar, Sharanjot Saini, (unknown), Varahram Shahryari, Soichiro Yamamura, Yuichiro Tanaka, Taku Kato, Shahana Majid, Rajvir Dahiya	27
6	MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2 2017 ·Cell Death and Disease ·(unknown), Altaf A. Dar, Sharanjot Saini, (unknown), Varahram Shahryari, Soichiro Yamamura, Yuichiro Tanaka, Gary S. Stein, Rajvir Dahiya, Shahana Majid	107
7	Pre-clinical Orthotopic Murine Model of Human Prostate Cancer 2016 ·Journal of Visualized Experiments ·Varahram Shahryari, (unknown), Sharanjot Saini, Altaf A. Dar, Soichiro Yamamura, Yozo Mitsui, (unknown), Nathan Bucay, Laura Tabatabai, Kirsten L. Greene, Guoren Deng, Yuichiro Tanaka, Rajvir Dahiya, Shahana Majid	9
8	Antitumor Activity of miR-1280 in Melanoma by Regulation of Src 2014 ·Molecular Therapy ·(unknown), Wen Zhou, Mehdi Nosrati, Shahana Majid, Suresh Thummala, David de Semir, Vladimir Bezrookove, Sébastien de Feraudy, (unknown), Dirk Schadendorf, Robert J. Debs, Mohammed Kashani–Sabet, Altaf A. Dar	21
9	The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression 2013 ·JNCI Journal of the National Cancer Institute ·Altaf A. Dar, Shahana Majid, (unknown), David de Semir, Vladimir Bezrookove, (unknown), Mehdi Nosrati, Richard W. Sagebiel, James R. Miller, Mohammed Kashani–Sabet	92
10	miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways 2012 ·Clinical Cancer Research ·Shahana Majid, Altaf A. Dar, Sharanjot Saini, Varahram Shahryari, Sumit Arora, Mohd Saif Zaman, Inik Chang, Soichiro Yamamura, Yuichiro Tanaka, Takeshi Chiyomaru, Guoren Deng, Rajvir Dahiya	96
11	Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis 2012 ·Proceedings of the National Academy of Sciences ·David de Semir, Mehdi Nosrati, Vladimir Bezrookove, Altaf A. Dar, Scot Federman, G. Bienvenu, Suraj Venna, Javier Rangel, Joan Climent, Tanja Tamgüney, Suresh Thummala, (unknown), Stanley P. L. Leong, Chris Haqq, Paul R. Billings, James R. Miller, Richard W. Sagebiel, Robert J. Debs, Mohammed Kashani–Sabet	30
12	miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer 2012 ·Cancer Research ·Shahana Majid, Altaf A. Dar, Sharanjot Saini, Sumit Arora, Varahram Shahryari, Mohd Saif Zaman, Inik Chang, Soichiro Yamamura, Yuichiro Tanaka, Guoren Deng, Rajvir Dahiya	125
13	MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer 2012 ·PLoS ONE ·Shahana Majid, Altaf A. Dar, Sharanjot Saini, Varahram Shahryari, Sumit Arora, Mohd Saif Zaman, Inik Chang, Soichiro Yamamura, Takeshi Chiyomaru, Shinichiro Fukuhara, Yuichiro Tanaka, Guoren Deng, Z. Laura Tabatabai, Rajvir Dahiya	54
14	MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer 2011 ·Cancer Research ·Shahana Majid, Sharanjot Saini, Altaf A. Dar, Hiroshi Hirata, Varahram Shahryari, Yuichiro Tanaka, Soichiro Yamamura, Koji Ueno, Mohd Saif Zaman, Kamaldeep Singh, Inik Chang, Guoren Deng, Rajvir Dahiya	120
15	miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein 2011 ·Journal of Biological Chemistry ·Altaf A. Dar, Shahana Majid, David de Semir, Mehdi Nosrati, Vladimir Bezrookove, Mohammed Kashani–Sabet	202
16	Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer 2010 ·Cancer Research ·Shahana Majid, Altaf A. Dar, Sharanjot Saini, Yi Chen, Varahram Shahryari, Jan Liu, Mohd Saif Zaman, Hiroshi Hirata, Soichiro Yamamura, Koji Ueno, Yuichiro Tanaka, Rajvir Dahiya	117
17	Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma 2010 ·Journal of Investigative Dermatology ·Altaf A. Dar, Shahana Majid, Mehdi Nosrati, David de Semir, Scot Federman, Mohammed Kashani–Sabet	26
18	Ribozyme-Mediated Targeting of IκBγ Inhibits Melanoma Invasion and Metastasis 2009 ·American Journal Of Pathology ·Sima Torabian, David de Semir, Mehdi Nosrati, (unknown), Altaf A. Dar, Sylvia Fong, Yong Liu, Scot Federman, Jeff Simko, Chris Haqq, Robert J. Debs, Mohammed Kashani–Sabet	8
19	Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells 2008 ·Clinical Cancer Research ·Abbes Belkhiri, Altaf A. Dar, Dunfa Peng, (unknown), Cammie Rinehart, Carlos L. Arteaga, Wael El‐Rifai	37
20	Early Involvement of Death-Associated Protein Kinase Promoter Hypermethylation in the Carcinogenesis of Barrett's Esophageal Adenocarcinoma and Its Association with Clinical Progression 2007 ·Neoplasia ·Doerthe Kuester, Altaf A. Dar, (unknown), Sabine Krueger, Frank Meyer, Roland Hartig, Manfred Stolte, Peter Malfertheiner, H. Lippert, Albert Roessner, Wael El‐Rifai, Regine Schneider‐Stock	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact